CJC and Ipamorelin Combination
Quick answer: CJC-1295 is a GHRH analog and Ipamorelin is a selective ghrelin-receptor agonist. Researchers use the pair as a model of sustained versus pulsatile growth hormone release, with studies measuring outcomes such as body composition, lipid metabolism and tissue repair markers. Transparent Peptides lists it as CJC-1295 & Ipamorelin 10mg (one vial, 5mg of each peptide) for laboratory research use only.
The combined use of CJC and Ipamorelin is a widely studied research combination in the field of growth hormone regulation. Researchers have investigated the peptides’ dual action as a model of stable, sustained growth hormone release, measuring outcomes such as body composition and tissue repair markers. Because growth hormone levels decline with age, the combination is also of interest in research on age-related changes in the GH axis. This blend is supplied for laboratory research use only and is not for human consumption.
CJC and Ipamorelin Combination: Research Highlights
- Studied in research on lean mass and body composition.
- Investigated in preclinical studies of lipid metabolism.
- Studied in preclinical models of tissue repair.
- Of interest in research on age-related GH decline.
- Relatively selective GH release reported in published studies.
- Researchers have examined endurance-related outcomes in animal models.
Transparent Peptides lists this combination as CJC-1295 & Ipamorelin 10mg (one vial, 5mg of each peptide, lyophilized powder), sold for laboratory research use only.
CJC-1295 and Ipamorelin Research Notes
- CJC-1295 is a GHRH analog, while Ipamorelin is a selective ghrelin-receptor agonist that, in published studies, was not associated with significant cortisol increases.
- Researchers use the pair as a model of sustained versus pulsatile GH release.
The two peptides are also listed as separate single vials: CJC DAC 5mg, CJC NO DAC 5mg, Ipamorelin 5mg and Ipamorelin 10mg (lyophilized powder). Research use only.
FAQ
Why are CJC-1295 and ipamorelin studied together?
CJC-1295 is a GHRH analog, while ipamorelin is a selective ghrelin-receptor agonist. Researchers use the pair as a model of sustained versus pulsatile growth hormone release.
What outcomes have researchers measured with the CJC-1295 and ipamorelin combination?
Studies have looked at lean mass and body composition, lipid metabolism, preclinical tissue repair models, age-related GH decline and endurance-related outcomes in animal models.
Is ipamorelin associated with cortisol increases in studies?
In published studies, ipamorelin was not associated with significant cortisol increases.
How is the CJC-1295 and ipamorelin blend supplied?
Transparent Peptides lists it as CJC-1295 & Ipamorelin 10mg: one vial with 5mg of each peptide as lyophilized powder, for laboratory research use only.
All products sold by Transparent Peptides are intended strictly for laboratory research use only (RUO). They are not for human consumption, are not drugs, foods or cosmetics, and are not intended to diagnose, treat, cure or prevent any disease. The information in this article summarizes published research and is provided for educational purposes only.


